Continue to site >
Trending ETFs

Kairos Pharma, Ltd.

Stock (ARCX)
KAPA
Payout Change
None
Price as of:
$1.61 +0.2 +0%
Dividend (Fwd)
$0.00
Yield (Fwd)
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
0.00%
KAPA: ARCX (Stock)

Kairos Pharma, Ltd.

Payout Change
None
Price as of:
$1.61 +0.2 +0%
Dividend (Fwd)
$0.00
Yield (Fwd)
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
0.00%
KAPA: ARCX (Stock)

Kairos Pharma, Ltd.

$1.61 +0%
Dividend (Fwd)
$0.00
Yield (Fwd)
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
0.00%
Payout Change
None
Analysis

Name

As of 10/14/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

  & DIV

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

Kairos Pharma, Ltd.

KAPA | stock

$1.61

14.18%

-

0.00%

$0.00

-

Dividend Data
Stock Data
Payout Ratio (FWD)
Fwd Payout Ratio is used to examine if a company’s earnings can support the current dividend payment amount. It divides the Forward Annualized Dividend by FY1 EPS. Click here to learn more.
N/A
Years of Dividend Increase
Consecutive Years of Dividend Increase is the number of years in a row in which there has been at least one payout increase and no payout decreases.
0 yrs
Dividend Frequency
N/A
Health Care Avg Yield
N/A
5 best health care dividend stocks
Market Cap
N/A
Day’s Range
$1.48 - $1.64
Volume
44,138
52 Wk Low/High
$1.22 - $4.0
Percent off 52 Wk High
-59.75%
FY1 PE
N/A
FY1 EPS / Growth
N/A / N/A

Name

As of 10/14/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

  & DIV

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

Kairos Pharma, Ltd.

KAPA | stock

$1.61

14.18%

-

0.00%

$0.00

-

Ratings - KAPA

Dividend Safety

?

Years of consecutive dividend increase.

Yield Attractiveness

?

Forward dividend yield

Returns Risk

?

Beta.

Returns Potential

?

Price target upside according to sell-side analysts.

Quant Recommendation - KAPA

Ratings analysis incomplete due to data availability. Recommendations not provided.

Maximize Income Goal

See Best High Dividend Stocks Model Portfolio for our top maximize income ideas.

Retirement Income Goal

See Best Dividend Protection Stocks Model Portfolio for our top retirement income ideas.

Monthly Income Goal

See Best Monthly Dividend Stocks Model Portfolio for our top monthly income ideas.

Growth Goal

See Best Dividend Growth Stocks Model Portfolio for our top growth ideas.

Income & Growth Goal

See Best Dividend Stocks Model Portfolio for our top income & growth blend ideas.

Sector Income & Growth Goal

See Best Health Care Dividend Stocks Model Portfolio for our top income & growth blend ideas in Health Care.

KAPA Payout History (Paid, Declared and Estimated)

Declared
Paid
Estimated
Year Calendar Year Payout (USD) Calendar Year Payout Growth (USD) Pay Date Declared Date Ex-dividend Date Payout Amount (USD) Qualified Dividend? Payout Type Frequency Days Taken For Stock Price To Recover Yield on Cost

KAPA Dividend Growth CAGR

Dividend Capture Strategy for KAPA

Dividend capture strategy is based on KAPA’s historical data. Past performance is no guarantee of future results.

Step 1: Buy KAPA shares 1 day before the ex-dividend date

Purchase Date (Estimate)

N/A

Upcoming Ex-Dividend Date

N/A

Step 2: SEll KAPA shares when price recovers

Sell Date (Estimate)

N/A

Avg Price Recovery

N/A

Avg yield on cost

N/A

See Full History

News & Research

News

Sorry, there are no articles available for this stock.

Research

Sorry, there are no articles available for this stock.

Company Profile

Company Overview

Exchanges: ARCX

Sector: Health Care

Industry: Biotech Pharma

No company description available.

Related Companies

Company Name

Price

Change

% Change

MANNKIND CORP

$6.45

-$0.03

-0.463%

Novelion Therapeutics Inc

$0.68

-$0.02

-2.857%

Nordic Nanovector ASA

$1.64

$1.64

0.000%

Nvest Inc

$0.16

$0.06

60.000%

Intec Parent Inc

$9.63

-$1.37

-12.455%

NS Wind Down Co., Inc.

$0.07

$0.00

0.000%

Newgistics Inc

$0.00

$0.00

-100.000%

© 2020&nbsp Market data provided is at least 15-minutes delayed and hosted by Barchart Solutions.

Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use, please see disclaimer